The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Prevalence of chronic liver disease in the general population of northern Italy: The dionysos study
Abstract
Data on the prevalence of chronic liver disease, derived from selected series of hospitalized patients or from mortality registers, underestimate the prevalence of chronic liver disease. The Dionysos Study is a cohort study that investigated for the first time the prevalence of chronic liver disease in a general population. All the citizens of two towns in northern Italy, Campogalliano and Cormons, aged 12 to 65 yr were contacted by letter. From March 1991 through March 1993, 6,917 of a total of 10,150 citizens were enrolled (compliance, 69%). The standardized protocol for each enrollee included (a) a color-illustrated food questionnaire on dietary habits and alcohol intake; (b) a detailed medical history, including questions on risk factors for chronic liver disease; (c) a physical examination; and (d) blood tests for AST, ALT, γ-glutamyl-transpeptidase, mean cell volume, platelet count and hepatitis B virus and hepatitis C virus markers. Signs suggestive of chronic liver disease were seen in 21.3% of the subjects, and who then underwent further liver function tests, upper abdominal ultrasonography and, when necessary, liver biopsy. Persistent signs of chronic liver disease were present in 17.5% of the subjects, including 1.1% with cirrhosis and 0.07% with hepatocellular carcinoma. The prevalence rates of hepatitis B virus and hepatitis C virus positivity (second-generation enzyme-linked immunosorbent assay) were 1.3% and 3.2%, respectively. Alcohol abuse was the etiological agent in 23%. Other factors which predisposed subjects to chronic liver disease were age older than 35 yr, male sex, body mass index higher than 27, history of blood transfusion, drug addiction and presence of chronic liver disease in the subject's family. Cirrhosis was due to hepatitis B virus or hepatitis C virus in 37%, and alcohol was the cause in 26%. In those subjects with alcohol abuse, viral infection, especially hepatitis C virus, played an important role in the deterioration of chronic liver disease and its progression to hepatocellular carcinoma. We conclude that the Dionysos study, the first study of the prevalence of chronic liver disease in a general population of northern Italy, found a much higher prevalence of chronic liver disease than reported previously in selected populations from Western countries. Hepatitis viral infections and alcoholism were the most important causative agents. (Hepatology 1994;20:1442-1449).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
A DATA-BASED APPROACH TO DIET QUESTIONNAIRE DESIGN AND TESTING
BLOCK, G., HARTMAN, A. M., DRESSER, C. M., CARROLL, M. D., GANNON, J., & GARDNER, L. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114416 · Cited by 2,163
Epidemiological approaches to heart disease: the Framingham study
Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148
Statistical Methods for Rates and Proportions.
Plewis, I., & Fleiss, J. L. (1982) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2982107 · Cited by 1,731
Cholesterol and Mortality: 30 Years of Follow-up From the Framingham Study
Anderson, K. M. (1987) · JAMA · doi:10.1001/jama.1987.03390160062027 · Cited by 620
Survival and prognostic indicators in compensated and decompensated cirrhosis
D'amico, G., Morabito, A., Pagliaro, L., Marubini, E., & The Liver Study Group of ?V. Cervello? Hospital (1986) · Digestive Diseases and Sciences · doi:10.1007/bf01320309 · Cited by 575
Epidemiology of Alcoholic Liver Disease
Grant, B., Dufour, M., & Harford, T. (1988) · Seminars in Liver Disease · doi:10.1055/s-2008-1040525 · Cited by 536
Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in Southern Guangxi, China
Yeh, F.-S., Yu, M. C., Mo, C.-C., Luo, S., Tong, M. J., & Henderson, B. E. (1990) · Health Policy · doi:10.1016/0168-8510(90)90389-u · Cited by 324
Tabelle di composizione degli alimenti
Carnovale, E., & Miuccio, F. C. (1987) · European Food Composition Tables in Translation · doi:10.1007/978-3-642-82989-5_11 · Cited by 264
Nishioka, K., Watanabe, J., Furuta, S., Tanaka, E., Iino, S., Suzuki, H., Tsuji, T., Yano, M., Kuo, G., Choo, Q., et al. (1991) · Cancer · doi:10.1002/1097-0142(19910115)67:2<429::aid-cncr2820670218>3.0.co;2-# · Cited by 238
Cited by
Bedogni, G., Bellentani, S., Miglioli, L., Masutti, F., Passalacqua, M., Castiglione, A., & Tiribelli, C. (2006) · BMC Gastroenterology · doi:10.1186/1471-230x-6-33 · Cited by 3,042
Self-citationNonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679
Szczepaniak, L. S., Nurenberg, P., Leonard, D., Browning, J. D., Reingold, J. S., Grundy, S., Hobbs, H. H., & Dobbins, R. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,562
Updated definitions of healthy ranges for serum alanine aminotransferase levels
Prati, D., Taioli, E., Zanella, A., Torre, E. D., Butelli, S., Del Vecchio, E., Vianello, L., Zanuso, F., Mozzi, F., Milani, S., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00006 · Cited by 1,445
“From Centro Transfusionale e di Immunologia dei Trapianti, Laboratorio di Epidemiologia, Divisione di Ematologia, Istituto di Statistica Medica e Biometria, Cattedra di Gastroenterologia, and Istituto di Medicina Interna, IRCCS Ospedale Maggiore and Università degli Studi di Milano, Milan, Italy.”
BackgroundInfluentialThe prevalence and etiology of elevated aminotransferase levels in the United States
Clark, J. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00265-x · Cited by 1,360
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy
Bellentani, S., Saccoccio, G., Masutti, F., Crocè, L. S., Brandi, G., Sasso, F., Cristanini, G., & Tiribelli, C. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00004 · Cited by 1,265
Self-citationBedogni, G., Miglioli, L., Masutti, F., Tiribelli, C., Marchesini, G., & Bellentani, S. (2005) · Hepatology · doi:10.1002/hep.20734 · Cited by 1,263
Self-citationThe Treatment of Chronic Viral Hepatitis
Hoofnagle, J. H., & Di Bisceglie, A. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701303360507 · Cited by 946
Hamaguchi, M., Kojima, T., Itoh, Y., Harano, Y., Fujii, K., Nakajima, T., Kato, T., Takeda, N., Okuda, J., Ida, K., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01526.x · Cited by 906
Nonalcoholic fatty liver disease
Clark, J. M., Brancati, F. L., & Diehl, A. M. (2002) · Gastroenterology · doi:10.1053/gast.2002.33573 · Cited by 901
Metformin reverses fatty liver disease in obese, leptin-deficient mice.
Lin, H. Z., Yang, S. Q., Chuckaree, C., Kuhajda, F., Ronnet, G., & Diehl, A. M. (2000) · Nature Medicine · doi:10.1038/79697 · Cited by 673
Drinking habits as cofactors of risk for alcohol induced liver damage
Bellentani, S., Saccoccio, G., Costa, G., Tiribelli, C., Manenti, F., Sodde, M., Croce’, L. S., Sasso, F., Pozzato, G., Cristianini, G., et al. (1997) · Gut · doi:10.1136/gut.41.6.845 · Cited by 630
Self-citationEstimating progression to cirrhosis in chronic hepatitis C virus infection
Freeman, A. J., Dore, G. J., Law, M. G., Thorpe, M., Von Overbeck, J., Lloyd, A. R., Marinos, G., & Kaldor, J. M. (2001) · Hepatology · doi:10.1053/jhep.2001.27831 · Cited by 620
Farci, P., Shimoda, A., Wong, D., Cabezon, T., De Gioannis, D., Strazzera, A., Shimizu, Y., Shapiro, M., Alter, H. J., & Purcell, R. H. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15394 · Cited by 603
Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis
Ratziu, V., Bonyhay, L., Di Martino, V., Charlotte, F., Cavallaro, L., Sayegh-Tainturier, M.-H., Giral, P., Grimaldi, A., Opolon, P., & Poynard, T. (2002) · Hepatology · doi:10.1053/jhep.2002.33324 · Cited by 464
Impact of alcohol on the histological and clinical progression of Hepatitis C infection
Wiley, T. E., McCarthy, M., Breidi, L., McCarthy, M., & Layden, T. J. (1998) · Hepatology · doi:10.1002/hep.510280330 · Cited by 436
Nonalcoholic Fatty Liver Disease: An Underrecognized Cause of Cryptogenic Cirrhosis
Clark, J. M., & Diehl, A. M. (2003) · JAMA · doi:10.1001/jama.289.22.3000 · Cited by 428
Prevalence and risk factors of non‐alcoholic fatty liver disease among Korean adults
PARK, S. H., JEON, W. K., KIM, S. H., KIM, H. J., PARK, D. I., CHO, Y. K., SUNG, I. K., SOHN, C. I., KEUM, D. K., & KIM, B. I. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.04086.x · Cited by 422
Noninvasive diagnosis of liver cirrhosis using DNA sequencer–based total serum protein glycomics
Callewaert, N., Vlierberghe, H. V., Hecke, A. V., Laroy, W., Delanghe, J., & Contreras, R. (2004) · Nature Medicine · doi:10.1038/nm1006 · Cited by 418
Azoulay, D., Castaing, D., Krissat, J., Smail, A., Marin Hargreaves, G., Lemoine, A., Emile, J.-F., & Bismuth, H. (2000) · Annals of Surgery · doi:10.1097/00000658-200011000-00008 · Cited by 397
Caronia, S., Taylor, K., Pagliaro, L., Carr, C., Palazzo, U., Petrik, J., O'Rahilly, S., Shore, S., Tom, B. D., & Alexander, G. J. M. (1999) · Hepatology · doi:10.1002/hep.510300416 · Cited by 396
American Gastroenterological Association Technical Review on the Management of Hepatitis C
Dienstag, J. L., & McHutchison, J. G. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.010 · Cited by 384
Epidemiology and natural history of hepatocellular carcinoma
McGlynn, K. A., & London, W. T. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2004.10.004 · Cited by 373
Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial
Nair, S., Diehl, A. M., Wiseman, M., Farr, G. H., & Perrillo, R. P. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02025.x · Cited by 369
Hepatitis C Virus Genotypes and Risk of Hepatocellular Carcinoma in Cirrhosis: A Prospective Study
Bruno, S., Silini, E., Crosignani, A., Borzio, F., Leandro, G., Bono, F., Asti, M., Rossi, S., Larghi, A., Cerino, A., et al. (1997) · Hepatology · doi:10.1002/hep.510250344 · Cited by 358
Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach
Cammà, C., Giunta, M., Andreone, P., & Craxı̀, A. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00005-8 · Cited by 356
Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders
Silvestri, F., Pipan, C., Barillari, G., Zaja, F., Fanin, R., Infanti, L., Russo, D., Falasca, E., Botta, G., & Baccarani, M. (1996) · Blood · doi:10.1182/blood.v87.10.4296.bloodjournal87104296 · Cited by 341
Corrao, G., & Aricò, S. (1998) · Hepatology · doi:10.1002/hep.510270404 · Cited by 324
Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)
Bellentani, S., & Marino, M. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31820-4 · Cited by 322
Self-citationNoninvasive in vivo quantitative assessment of fat content in human liver
Ricci, C., Longo, R., Gioulis, E., Bosco, M., Pollesello, P., Masutti, F., Crocè, L. S., Paoletti, S., Bernard, B. D., Tiribelli, C., et al. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80288-7 · Cited by 314
Self-citationVandelli, C., Renzo, F., Romano, L., Tisminetzky, S., De Palma, M., Stroffolini, T., Ventura, E., & Zanetti, A. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04150.x · Cited by 310
Donadon, V., Balbi, M., Mas, M. D., Casarin, P., & Zanette, G. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02223.x · Cited by 292
Racial differences in responses to therapy with interferon in chronic hepatitis C
Reddy, R. K., Hoofnagle, J. H., Tong, M. J., Lee, W. M., Pockros, P., Heathcote, J. E., Albert, D., & Joh, T. (1999) · Hepatology · doi:10.1002/hep.510300319 · Cited by 291
Minimal hepatic encephalopathy impairs fitness to drive
Wein, C., Koch, H., Popp, B., Oehler, G., & Schauder, P. (2004) · Hepatology · doi:10.1002/hep.20095 · Cited by 291
Qureshi, K. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i26.3540 · Cited by 283
To C or not to C: these are the questions
Alter, H. (1995) · Blood · doi:10.1182/blood.v85.7.1681.bloodjournal8571681 · Cited by 280
Chen, G., Lin, W., Shen, F., Iloeje, U. H., London, W. T., & Evans, A. A. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00647.x · Cited by 275
An update on the role of free radicals and antioxidant defense in human disease
Vendemiale, G., Grattagliano, I., & Altomare, E. (1999) · International Journal of Clinical & Laboratory Research · doi:10.1007/s005990050063 · Cited by 269
Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis
Aubé, C., Oberti, F., Korali, N., Namour, M.-A., Loisel, D., Tanguy, J.-Y., Valsesia, E., Pilette, C., Rousselet, M. C., Bedossa, P., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80107-x · Cited by 256
A simple index of lipid overaccumulation is a good marker of liver steatosis
Bedogni, G., Kahn, H. S., Bellentani, S., & Tiribelli, C. (2010) · BMC Gastroenterology · doi:10.1186/1471-230x-10-98 · Cited by 253
Self-citationSun, C.-A. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg041 · Cited by 234
Youssef, N. A., Abdelmalek, M. F., Binks, M., Guy, C. D., Omenetti, A., Smith, A. D., Diehl, A. M. E., & Suzuki, A. (2013) · Liver International · doi:10.1111/liv.12165 · Cited by 182
Depression and chronic liver diseases: are there shared underlying mechanisms?
Huang, X., Liu, X., & Yu, Y. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00134 · Cited by 121
“In addition, a number of studies on CLD have instead used self-report questionnaires (Bellentani et al., 1994; Dwight et al., 2000; Dan et al., 2006).”
BackgroundFosby, B., Melum, E., Bjøro, K., Bennet, W., Rasmussen, A., Andersen, I. M., Castedal, M., Olausson, M., Wibeck, C., Gotlieb, M., et al. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1036359 · Cited by 99
Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma
Donadon, V. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i24.3025 · Cited by 66
Murine Models of Acute Alcoholic Hepatitis and Their Relevance to Human Disease
Wilkin, R. J. W., Lalor, P. F., Parker, R., & Newsome, P. N. (2016) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.12.003 · Cited by 36
Cividini, A., Pistorio, A., Regazzetti, A., Cerino, A., Tinelli, C., Mancuso, A., Ribola, M., Galli, M. L., Agnusdei, A., Leone, M., et al. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80348-0 · Cited by 35
The cirrhosis epidemic in the UK: evaluating the causes in a European context
McAvoy, N. C., & Hayes, P. C. (2007) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.1.1.41 · Cited by 14
Metadata
- Authors
- Bellentani, S., Tiribelli, C., Saccoccio, G., Sodde, M., Fratti, N., De Martin, C., & Christianini, G.
- Venue
- Hepatology
- Published
- 1994-12
- Volume
- 20
- Issue
- 6
- Pages
- 1442-1449
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2112258271
- Cited by
- 517
- References
- 28
- FWCI
- 13.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.